Drug delivery systems for the treatment of periodontal and dental diseases

Drug Delivery to the Oral Cavity: Molecules to Market

Volumn , Issue , 2005, Pages 211-232

  Yum, Su Il ^a   Yum, Eric ^b  

^a DURECT Corporation   (United States)

^b Camarillo Dental Practice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750143143     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (35)

1. Fuks AB, Holan G, Davis JM, Eidelman E. Ferric sulfate versus dilute formocresol in pulpotomized primary molars: Long-term follow-up. Pediatr Dent 1997; 19(5):327-330.
2. Negm MM. Effect of intracanal use of nonsteroidal anti-inflammatory agents on post-treatment endodontic pain. Oral Surg Oral Med Oral Pathol 1994; 77(5):507-513.
3. Ogaard B, Larsson E, Glans R, Henriksson T, Birkhed D. Antibacterial effect of a chlorhexidine-thymol varnish (Cervitec) in orthodontic patients: A prospective, randomized clinical trial. J Orofac Orthop 1997; 58(4):206-213.
4. Twetman S, Hallgren A, Petersson LG. Effect of an antibacterial varnish on mutans Streptococci in plaque from enamel adjacent to orthodontic appliances. Caries Res 1995; 29(3):188-191.
5. Wiltshire WA. Determination of fluoride from fluoride-releasing elastomeric ligature ties. Am J Orthod Dentofacial Orthop 1996; 110(4):383-387.
6. Trimpeneers LM, Dermaut LR. A clinical evaluation of the effectiveness of a fluoridereleasing visible light-activated bonding system to reduce demineralization around orthodontic brackets. Am J Orthod Dentofacial Orthop 1996; 110(2):218-222.
7. Isotupa KP, Gunn S, Chen CY, Lopatin D, Makinen KK. Effects of polyol gums on dental plaque in orthodontic patients. Am J Orthod Dentofacial Orthop 1995; 107(5):497-504.
8. Bragger U, Muhle T, Fourmonsis I, Lang NP, Mombelli A. Effect of the NSAID flurbiprofen on remodeling after periodontal surgery. J Periodontal Res 32(7):575-582.
9. O’Brian TP, Ruszkowski MT, Wolff LF, Hinrichs JE, Hargreeves KM. Effect of a non-steroidal anti-inflammatory drug on tissue levels of immunoreactive prostaglandin E2, immunoreactive leukotriene, and pain after periodontal surgery. J Periodontal 1996; 67(12):1307-1316.
10. Li KL, Vogel R, Jeffcoat MK, Alfano MC, Smith MA, Collins JG, Offenbacher S. The effect of ketoprofen creams on periodontal disease in rhesus monkeys. J Periodontal Res 1996; 31(8):525-532.
11. Haffajec AD, Socransky SS, Dibart S, Kent RL, Jr. Response to periodontal therapy in patients with high or low levels of P. gingivalis, P. intermedia, P. nigrescans and B. forsythus. J Clin Periodontal 1996; 23(4):336-345.
12. Furuichi Y, Ramberg P, Krok L, Lindhe J. Short-term effects of triclosan on healing following subgingival scaling. J Clin Periodontal 1997; 24(10):777-782.
13. Seppa L. A Review. Proc Finn Dent Soc 1991; 87(4):541-547.
14. Ogaard B, Larsson E, Glans R, Henriksson T, Birhed D. Antimicrobial effect of chlorhexidine-thymol varnish Cervitec in orthodontic patients: A prospective, randomized clinical trial. J Orofac Orthop 1997; 58(4):206-213.
15. Lindquist L, Otteskog P. Engenol: Liberation from dental materials and effect on human diploid fibroblast cells. Scand J Dent Res 1980; 88(6):552-556.
16. Wright K, Barbosa S, Araki K, Spangberg L. In vitro antimicrobial and cytotoxic effects of Kri 1 paste and zinc oxide-eugenol used in primary tooth pulpectomies. Pediatric Dentistry 1994; 16(2):102-106.
17. Wiltshire WA. Determination of fluoride from fluoride-releasing elastomeric ligature ties. Am J Orthod Dentofacial Orthop 1996; 110(4):383-387.
18. Petersson LG, Edwardsson S, Arends J. Antimicrobial effect of a dental varnish, in vitro. Swed Den J 1992; 16(5):183-189.
19. Actisite® (tetracycline hydrochloride) periodontal Fiber Product Information. ALZA Corporation (1998).
20. Author unknown. Antibiotic gels for periodontal disease. Drug Ther Bull 1994; 32(6):43-44.
21. Soskolne A, Freidman M. Intra-periodontal pocket drug delivery systems. In: Rathbone MJ, ed. Oral Mucosal Drug Delivery. New York: Marcel Dekker, 1992: Chap. 14.
22. Stoltze K. Elimination of Elyzol 25% dentalgel matrix from periodontal pockets. J Clin Periodontal 1995; 22 (3):185-187.
23. Steinberg D, Friedman M, Soskolne A, Sela MN. A new degradable controlling release device for treatment of periodontal disease: In vitro release study. J Periodontal 1990; 61 (7):393-398.
24. Perio Products Ltd, Jerusalem, Israel 1998 Perio Chips Platform.
25. Hagiwara, S, Takamatsu N, Tominaga Y, Umeda M. Subgingival distribution of periodontopathic bacteria in adult periodontitis and their susceptibility to minocycline-HCl. J Periodontal 1998; 69 (1):92-99.
26. Nakagawa T, Yamada S, Oosuka Y, Saito A, Hosaka Y, Ishikawa T, Okuda K. Clinical and microbiological study of local minocycline delivery (Periocline®) following scaling and root planing in recurrent periodontal pockets. Bull Tokyo Dent Coll 1991; 32 (2):63-70.
27. Holan G, Fuks AB. A comparison of pulpectomies using ZOE and KRI paste in primary molars: A retrospective study. Pediatr Dent 1993; 15(6):403-407.
28. Wilson TG, Gregory RL. Clinical effectiveness of fluoride releasing elastomers I:Salivary streptococcus mutans numbers. Am J Orthod Dentofacial Orthop 1995; 107(3):293-297.
29. Wilson TG, Love B. Clinical effectiveness of fluoride-releasing elastomers II: Enamel microhardness levels. Am J Orthod Dentofacial Orthop 1995; 107(4):379-381.
30. Seppa L. Studies of fluoride varnishes in Finland. Proc Finn Dent Soc 1991; 87(4):541-547.
31. Twetman S, Hallgren A, Petersson LG. Effect of an antibacterial varnish on mutans Streptococci in plaque from enamel adjacent to orthodontic appliances. Caries Res 1995; 29(3):199-191.
32. Weiger R, Friedrich C, Netachil L, Schlagenhauf U. Effect of chlorhexidine-containing varnish (Cervitec) on microbial vitality and accumulation of supragingivel dental plaque in humans. Caries Res 1994; 28(4):267-271.
33. U.S. Department of Health, Education, and Welfare. Guidelines for the clinical evaluation of drugs to prevent dental caries. Public Health Service, Food and Drug Administration, issued November 1978.
34. U.S. Department of Health, Education, and Welfare. Guidelines for the clinical evaluation of drugs to prevent, control, and/or treat periodontal diseases. Public Health Service, Food and Drug Administration issued November 1978.
35. U.S. Department of Health, Education and Welfare. Guidelines for the clinical evaluation of drugs to prevent dental caries. Public Health Service, Food and Drug Administration issued November 1978.